378 related articles for article (PubMed ID: 18703227)
1. Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia.
Escudero C; Casanello P; Sobrevia L
Placenta; 2008 Sep; 29(9):816-25. PubMed ID: 18703227
[TBL] [Abstract][Full Text] [Related]
2. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.
Muñoz G; San Martín R; Farías M; Cea L; Vecchiola A; Casanello P; Sobrevia L
J Cell Physiol; 2006 Dec; 209(3):826-35. PubMed ID: 16924660
[TBL] [Abstract][Full Text] [Related]
3. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium.
Casanello P; Torres A; Sanhueza F; González M; Farías M; Gallardo V; Pastor-Anglada M; San Martín R; Sobrevia L
Circ Res; 2005 Jul; 97(1):16-24. PubMed ID: 15933265
[TBL] [Abstract][Full Text] [Related]
4. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of functional nucleoside transporters in non-differentiated and differentiated human endothelial progenitor cells.
Guzmán-Gutiérrez E; Sandoval C; Nova E; Castillo JL; Vera JC; Lamperti L; Krause B; Salomón C; Sepúlveda C; Aguayo C; Sobrevia L
Placenta; 2010 Oct; 31(10):928-36. PubMed ID: 20728214
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.
Farías M; San Martín R; Puebla C; Pearson JD; Casado JF; Pastor-Anglada M; Casanello P; Sobrevia L
J Cell Physiol; 2006 Aug; 208(2):451-60. PubMed ID: 16688763
[TBL] [Abstract][Full Text] [Related]
8. PP003. Antagonism in A2A and A2B adenosine receptor on fetal endothelium proliferation involves a nitric oxide-depended intracellular pathway in early and late-onset pre-eclampsia.
Acurio J; Escudero A; Celis C; Bertoglia P; Escudero C
Pregnancy Hypertens; 2012 Jul; 2(3):241-2. PubMed ID: 26105325
[TBL] [Abstract][Full Text] [Related]
9. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.
Puebla C; Farías M; González M; Vecchiola A; Aguayo C; Krause B; Pastor-Anglada M; Casanello P; Sobrevia L
J Cell Physiol; 2008 Jun; 215(3):645-56. PubMed ID: 18064606
[TBL] [Abstract][Full Text] [Related]
10. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.
Jennings LL; Hao C; Cabrita MA; Vickers MF; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 2001 Apr; 40(5):722-31. PubMed ID: 11311901
[TBL] [Abstract][Full Text] [Related]
11. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
12. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
Elwi AN; Damaraju VL; Kuzma ML; Mowles DA; Baldwin SA; Young JD; Sawyer MB; Cass CE
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1439-51. PubMed ID: 19297449
[TBL] [Abstract][Full Text] [Related]
13. Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes.
Sobrevia L; Abarzúa F; Nien JK; Salomón C; Westermeier F; Puebla C; Cifuentes F; Guzmán-Gutiérrez E; Leiva A; Casanello P
Placenta; 2011 Mar; 32 Suppl 2():S159-64. PubMed ID: 21215450
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes.
Farías M; Puebla C; Westermeier F; Jo MJ; Pastor-Anglada M; Casanello P; Sobrevia L
Cardiovasc Res; 2010 Apr; 86(1):45-54. PubMed ID: 20032083
[TBL] [Abstract][Full Text] [Related]
15. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A
Acurio J; Herlitz K; Troncoso F; Aguayo C; Bertoglia P; Escudero C
Purinergic Signal; 2017 Mar; 13(1):51-60. PubMed ID: 27696086
[TBL] [Abstract][Full Text] [Related]
17. Intracellular acidification increases adenosine transport in human umbilical vein endothelial cells.
Celis N; Araos J; Sanhueza C; Toledo F; Beltrán AR; Pardo F; Leiva A; Ramírez MA; Sobrevia L
Placenta; 2017 Mar; 51():10-17. PubMed ID: 28292464
[TBL] [Abstract][Full Text] [Related]
18. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
[TBL] [Abstract][Full Text] [Related]
19. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin.
Salomón C; Westermeier F; Puebla C; Arroyo P; Guzmán-Gutiérrez E; Pardo F; Leiva A; Casanello P; Sobrevia L
PLoS One; 2012; 7(7):e40578. PubMed ID: 22808198
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
